Apixaban and Aripiprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Apixaban (apixaban) and Aripiprazole (aripiprazole). Common drug interactions include thrombocytopenia among females and drug-induced liver injury among males.
The phase IV clinical study analyzes what interactions people have when they take Apixaban and Aripiprazole. It is created by eHealthMe based on reports of 125 people who take the same drugs from the FDA, and is updated regularly.
What is Apixaban?
Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.
What is Aripiprazole?
Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.
125 people who take Apixaban and Aripiprazole together, and have interactions are studied.
What are the common drug interactions of Apixaban and Aripiprazole, by gender? *
What are the common drug interactions of Apixaban and Aripiprazole, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Apixaban and Aripiprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Apixaban (60,351 reports)
- Aripiprazole (39,143 reports)
Browse all drug interactions of Apixaban and Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Apixaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Apixaban and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aripiprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on apixaban and aripiprazole (the active ingredients of Apixaban and Aripiprazole, respectively), and Apixaban and Aripiprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lexapro and Multihance - 8 seconds ago
- Could Pulmicort cause Gastritis Erosive? - 28 seconds ago
- Drug interactions of Eliquis and Solu-Medrol - 38 seconds ago
- Drug interactions of Rocephin and Itraconazole - 50 seconds ago
- Drug interactions of Invanz and Digoxin - 51 seconds ago
- Drug interactions of Nexplanon and Nasonex - 52 seconds ago
- Drug interactions of Potassium and Ubrelvy - a minute ago
- Could Benadryl cause Procedural Hypotension? - a minute ago
- Drug interactions of Glucosamine and Fosaprepitant - a minute ago
- Drug interactions of Lupron and Xalatan - a minute ago